# Clinical efficacy of traditional Chinese medicine compound on patients with knee osteoarthritis and its impact on inflammatory cytokine levels

**Authors:** Kui Wang, Zuoyuan Wu, Xiangnan Shen, Yanjun Wang, Chenglin Mu

PMC · DOI: 10.12669/pjms.41.7.10724 · Pakistan Journal of Medical Sciences · 2025-07-01

## TL;DR

This study shows that a traditional Chinese medicine compound can reduce pain and inflammation in knee osteoarthritis patients more effectively than standard treatment.

## Contribution

The study demonstrates the superior clinical efficacy and anti-inflammatory effects of a TCM compound in treating knee osteoarthritis.

## Key findings

- The TCM compound significantly reduced pain levels (VAS scores) more than the control group.
- The TCM group showed greater improvement in knee joint function (Lysholm scores) and inflammatory markers (CRP, IL-6, TNF-α).
- Quality of life (ADL scores) improved more in the TCM group compared to the control group.

## Abstract

To investigate the clinical efficacy of traditional Chinese medicine (TCM) compound in the treatment of knee osteoarthritis (KOA) and its impact on inflammatory cytokine levels.

A retrospective analysis was conducted on the medical records of 80 KOA patients admitted to Hebei Province Hospital of Chinese Medicine from January 2021 to January 2023. The patients were divided into an observation group and a control group based on different treatment methods (n=40 each group). The visual analogue scale (VAS) was adopted to assess patients’ pain level, and the Lysholm score was used to evaluate knee joint function, and the clinical outcomes of the two groups were compared.

After treatment, both groups exhibited a significant decrease in VAS scores, with the observation group showing a more substantial reduction(P<0.05). The Lysholm scores of both groups were significantly higher after treatment than before treatment (P<0.05). Serum levels of CRP, IL-6, and TNF-α decreased significantly in both groups after treatment, with the observation group showing a more pronounced reduction (P<0.05). The ADL scores for both advanced and basic abilities improved significantly post-treatment in both groups, with the observation group demonstrating a statistically significant greater improvement (P<0.05). The treatment efficacy for the observation group was 92.50%, which was significantly higher than the control group’s rate of 77.50% (χ²=4.114, P<0.05).

Traditional Chinese Medicine(TCM) compound therapy for KOA can significantly alleviate patients’ pain, reduce the expression of inflammatory factors in serum, enhance knee joint function, and improve patients’ quality of life.

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** KOA (MESH:D020370), inflammatory (MESH:D007249), pain (MESH:D010146)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12302083/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12302083/full.md

---
Source: https://tomesphere.com/paper/PMC12302083